| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/15/2012 | EP2417128A2 6-(3-aza-bicycloý3.1.0¨hex-3-yl)-2-phenyl-pyrimidines |
| 02/15/2012 | EP2417127A1 Kinase inhibitors and method of treating cancer with same |
| 02/15/2012 | EP2417126A1 Hepatitis c virus inhibitors |
| 02/15/2012 | EP2417125A1 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors |
| 02/15/2012 | EP2417123A2 Therapeutic compositions and related methods of use |
| 02/15/2012 | EP2417122A1 Indole derivatives and methods for antiviral treatment |
| 02/15/2012 | EP2417112A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof |
| 02/15/2012 | EP2417110A2 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4]non-1-en-4-one (irbesartan) |
| 02/15/2012 | EP2417108A1 Organic compounds and their uses |
| 02/15/2012 | EP2081925B1 Benzoylpyrazoles, their use as herbicides, and intermediates |
| 02/15/2012 | EP1819680B1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 02/15/2012 | EP1771441B8 Novel carboxamides for use as xa inhibitors |
| 02/15/2012 | CN102356075A Compositions and methods for inhibition of the jak pathway |
| 02/15/2012 | CN102356074A Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics |
| 02/15/2012 | CN102351907A Method for synthesizing metal N-heterocyclic carbene complex |
| 02/15/2012 | CN102351848A Rotenone cyclopropanecarboxamide and its preparation method and use |
| 02/15/2012 | CN101044114B 硝基苯并吲哚和它们在癌症疗法中的用途 Nitrobenzene and indole and their use in cancer therapy in the |
| 02/14/2012 | US8115009 UV-absorbers for ophthalmic lens materials |
| 02/14/2012 | US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/14/2012 | US8114885 Chemical compounds |
| 02/14/2012 | US8114884 CXCR4 antagonists for the treatment of medical disorders |
| 02/14/2012 | US8114882 Antitumor agents; kinase inhibitors; angiogenesis inhibitors; arteriosclerosis ; antiinflammatory agents |
| 02/14/2012 | US8114879 Piperazine derivatives useful as CCR5 antagonists |
| 02/14/2012 | US8114876 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/14/2012 | US8114871 3-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivatives |
| 02/14/2012 | US8114865 Indazole derivatives as kinase inhibitors for the treatment of cancer |
| 02/14/2012 | US8114844 Linear and cyclic melanocortin receptor-specific peptidomimetics |
| 02/14/2012 | CA2463154C Heterocyclic compounds and methods of use |
| 02/09/2012 | WO2012018325A1 Hepatitis c virus inhibitors |
| 02/09/2012 | WO2012018059A1 Heterocyclic compound |
| 02/09/2012 | WO2012018058A1 Fused heterocyclic ring compound |
| 02/09/2012 | WO2012017876A1 P2x4 receptor antagonist |
| 02/09/2012 | WO2012017020A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
| 02/09/2012 | WO2012016993A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 02/09/2012 | WO2012016569A1 Deuterated tandospirone derivatives as 5-ht1a receptor agonists |
| 02/09/2012 | WO2012016255A1 Compounds prepared from chlorophyll catabolites |
| 02/09/2012 | US20120035408 Compounds useful as inhibitors of atr kinase |
| 02/09/2012 | US20120035407 Compounds useful as inhibitors of atr kinase |
| 02/09/2012 | US20120035351 Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors |
| 02/09/2012 | US20120035328 Methods for forming dyed microspheres and populations of dyed microspheres |
| 02/09/2012 | US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 02/09/2012 | US20120035187 Anti-neurodegenerative disease agent |
| 02/09/2012 | US20120035154 Modulators of Cellular Adhesion |
| 02/09/2012 | US20120034186 Indoline scaffold shp-2 inhibitors and method of treating cancer |
| 02/09/2012 | US20120032158 Charge transport compositions and electronic devices made with such compositions |
| 02/09/2012 | CA2810150A1 P2x4 receptor antagonist |
| 02/09/2012 | CA2807305A1 Hepatitis c virus inhibitors |
| 02/09/2012 | CA2807198A1 Ligands for antibody and fc-fusion protein purification by affinity chromatography |
| 02/09/2012 | CA2807093A1 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase |
| 02/09/2012 | CA2806015A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
| 02/09/2012 | CA2805440A1 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
| 02/08/2012 | EP2416397A1 Material for phosphorescent light-emitting element and organic electroluminescent element using same |
| 02/08/2012 | EP2415769A1 Bis-carbazole derivative, material for organic electroluminescent element and organic electroluminescent element using same |
| 02/08/2012 | EP2415760A2 CCR-9 antagonists |
| 02/08/2012 | EP2414352A1 Hepatitis c virus inhibitors |
| 02/08/2012 | EP2414351A1 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative |
| 02/08/2012 | EP2414350A1 Hepatitis c virus inhibitors |
| 02/08/2012 | EP2414349A1 3-ý1,4¨oxazepane-4-pyrimidone derivatives |
| 02/08/2012 | EP2414348A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders |
| 02/08/2012 | EP2414328A2 Dihydroorotate dehydrogenase inhibitors |
| 02/08/2012 | EP2414327A1 Heterocyclic compounds as autotaxin inhibitors |
| 02/08/2012 | EP2413933A2 Composition of 2,4,6-trifluoro-n-ý6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl¨-benzamide |
| 02/08/2012 | EP2413701A1 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| 02/08/2012 | EP2148853B1 Insecticidal aryl pyrrolidines |
| 02/08/2012 | EP2144898B1 Heterocyclic hydrazide compound and pesticidal use of the same |
| 02/08/2012 | EP1509518B1 Calcium receptor modulating agents |
| 02/08/2012 | CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound |
| 02/08/2012 | CN102348708A Prodrug forms of kinase inhibitors and their use in therapy |
| 02/08/2012 | CN102348705A Compounds usable as materials for a hole injection layer or hole transport layer, and organic light-emitting diode using same |
| 02/08/2012 | CN102348704A Conjugate addition reactions using bifunctional cinchona-alkaloid-based catalysts |
| 02/08/2012 | CN102348703A Compounds for the treatment of metabolic disorders |
| 02/08/2012 | CN102348698A Inhibitors of beta-secretase |
| 02/08/2012 | CN102348683A Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient |
| 02/08/2012 | CN102344443A Open-loop maleimide compound utilizing click chemosynthesis and application in treating diseases thereof |
| 02/08/2012 | CN102344442A Novel crystal form of tandospirone citrate and preparation method and application thereof |
| 02/08/2012 | CN102344441A Technological improved method for preparing voriconazole intermediate |
| 02/08/2012 | CN102344398A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 02/08/2012 | CN101575318B 二氢嘧啶类化合物及其用于制备治疗和/或预防病毒性疾病的药物的用途 Dihydro-pyrimidine compounds and their use for preparing medicaments for treating and / or preventing viral drug |
| 02/08/2012 | CN101415687B 鞘氨醇-1-磷酸结合抑制物质 Sphingosine-1-phosphate binding-inhibiting substance |
| 02/08/2012 | CN101410394B 抑制人免疫缺陷病毒的5-(羟基亚甲基和氨基亚甲基)取代的嘧啶 Inhibition of human immunodeficiency virus 5- (hydroxymethylene and aminomethylene) pyrimidine substituted |
| 02/08/2012 | CN101321767B 用于专一性检测过亚硝酸根的试剂 For specific detection reagents peroxynitrite |
| 02/07/2012 | US8110687 Bicyclic compounds with kinase inhibitory activity |
| 02/07/2012 | US8110567 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/07/2012 | CA2663366C Compounds and compositions as protein kinase inhibitors |
| 02/07/2012 | CA2516514C Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 02/07/2012 | CA2486836C Multi-substituted imidazolines and method of use thereof |
| 02/07/2012 | CA2471044C Benzimidazole derivatives and their use as gnrh antagonists |
| 02/02/2012 | WO2012016001A1 Cyclic amine azaheterocyclic carboxamides |
| 02/02/2012 | WO2012015324A1 Process for the synthesis of substituted urea compounds |
| 02/02/2012 | WO2012015024A1 Ethinyl-pyrazole derivative |
| 02/02/2012 | WO2012014910A1 P2x4 receptor antagonist |
| 02/02/2012 | WO2012014221A1 Substituted 4-(4-fluoro-3-(piperazine-1- carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase- 1 inhibitors |
| 02/02/2012 | WO2012014000A1 STABLE α-CRYSTAL FORM OF IMATINIB MESYLATE AND PREPARING PROCESS THEREOF |
| 02/02/2012 | WO2012013716A1 Bicyclic acetyl-coa carboxylase inhibitors |
| 02/02/2012 | WO2012013643A1 Hetero-bicyclic derivatives as hcv inhibitors |
| 02/02/2012 | WO2012013282A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 02/02/2012 | WO2012012941A1 Bcl-2 family protein inhibitors, their cyclodextrin inclusion compounds, complexes, and uses in manufacture of bcl-2 family protein inhibitors thereof |
| 02/02/2012 | WO2011104555A3 Process for the preparation of sunitinib malate form i |
| 02/02/2012 | WO2011057973A9 Oxazoline derivatives for treatment of cns disorders |
| 02/02/2012 | WO2011005052A8 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same |